palatin.net
域名年龄: 24年9个月3天HTTP/1.1 301 永久重定向 连接:关闭 访问时间:2014年08月14日 12:23:34 服务器:Microsoft-IIS/6.0 语言环境:ASP.NET 目标网址:http://www.palatin.com/Default.asp 类型:text/html 设置Cookie:ASPSESSIONIDAQRSCQDS=IFBEMDMBGJCDDDPAKKHPEPFA; path=/ 缓存控制:private HTTP/1.1 200 OK 访问时间:2014年08月14日 12:23:34 服务器:Microsoft-IIS/6.0 语言环境:ASP.NET 类型:text/html 设置Cookie:ASPSESSIONIDAQRSCQDS=JFBEMDMBKKGBIDEEAOCBNPCL; path=/ 缓存控制:private Transfer-Encoding: chunked 页面编码:iso-8859-1
Contact Palatin Site Map . . . . . . 07-09-14 Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific... 06-27-14 Palatin Technologies to Join Russell Microcap Index... 06-10-14 Palatin Technologies Announces Notification of Patent Allowance On Next Generation Melanocortin Rec... Palatin Technologies, Inc. (NYSE Amex: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Our programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Our primary product in development is bremelanotide for the treatment of female sexual dysfunction. In addition, we have development programs or drug candidates for erectile dysfunction, pulmonary diseases, heart failure, obesity and inflammatory diseases. Palatin Corporate Presentation - May 2014 Overview Press Releases Event Calendar Webcasts SEC Filings Analyst Coverage Corporate Governance Investor Materials Overview Executive Management Board of Directors Overview Career Opportunities Overview Press Releases Presentations Events Calendar Webcasts Media Kit Overview PL-3994 for CHF PL-3994 for Asthma PL-3994 for Hypertension Bremelanotide PL-6983 Obesity Posters & Publications Overview Licensing and Collaboration Opportunities Terms of Use | Privacy Policy Copyright © Palatin Technologies, Inc. All rights reserved.
© 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询
2025-05-31 04:54, Process in 0.0066 second.